Publishing research using ab77077? Please let us know so that we can cite the reference in this datasheet.
ab77077 has been referenced in 4 publications.
Smith JP et al.Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.Cancer Immunol Immunother 67:195-207 (2018).
Smith JP et al.Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.Pancreas 43:1050-9 (2014).
Xu L et al.Heterobivalent ligands target cell-surface receptor combinations in vivo.Proc Natl Acad Sci U S A : (2012).
Berna MJ et al.CCK1 and CCK2 receptors are expressed on pancreatic stellate cells and induce collagen production.J Biol Chem 285:38905-14 (2010).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up